Concussion in French Non-professional Handball League : Efficiency of a Concussion Protocol, the White Card Process
Launched by UNIVERSITY HOSPITAL, BORDEAUX · Apr 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a concussion protocol used in French non-professional handball. The protocol, known as the "White Card Process," allows referees to temporarily remove players from the game if they suspect a concussion. This is important because concussions are a serious concern in contact sports, and having a clear process can help ensure players receive the necessary medical attention.
To participate in this study, individuals need to be over 18 years old, male or female, and must have received a white card during an official handball game. They should also have an email address registered with the French Handball Federation. Participants will be asked about their experiences and the impact of the protocol on their safety and health. The trial is currently recruiting, and all eligible players are encouraged to join to help improve player safety in the sport.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female
- • Over 18 years old
- • Who had received a white card during an official game
- • having an email address registered in the FFHB register
- Exclusion Criteria:
- • Any refusal to participate
- • Inability to respond
About University Hospital, Bordeaux
The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bordeaux, , France
Patients applied
Trial Officials
Helene CASSOUDESALLE
Principal Investigator
University Hospital, Bordeaux
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported